ESR2 and breast cancer: When compared to E2-modulating gene expression in MCF-7 breast cancer cells, ERβ botanical agonists are depicted to be less stimulatory on gene expression promoting proliferation and motility, while they are more effective in up-regulating apoptotic genes [164].